Looking for a potential new treatment option to help control your Graves' disease? Consider joining the FORWARD clinical trial to help advance research for people like you who are affected by Graves'
Who Can Participate?
This trial is enrolling people aged 18 to 75 who:
- Have been diagnosed with Graves' disease
- Have been taking antithyroid drugs (like tapazole) for at least 3 months by the time they begin the study
- Have not undergone Radioactive Iodine Therapy or complete thyroidectomy
Why Take Part?
Clinical trials are the only way to investigate potential new treatments. By participating, you may potentially benefit other people with Graves' disease in future generations. You will also receive attentive care from a team skilled in the treatment of Graves' disease throughout the trial.
There are other requirements which the study team will discuss with you. Learn more about our participation criteria to see if you may be a good fit for this trial.
What is Graves' Disease?
What exactly is Graves' Disease?
Graves' disease is caused by the body's disease-fighting immune system not working correctly. The same immune system that makes antibodies to target viruses, bacteria, or other foreign substances can make antibodies that target cells in the thyroid.
When this happens, it can cause a disruption in thyroid hormone production. The antibody linked with Graves' disease causes the thyroid to make more thyroid hormone than the body needs. That condition is called hyperthyroidism, and Graves' disease is the most common form of it.